EMAIL THIS PAGE TO A FRIEND

PloS one

New insights into the relationship between mIGF-1-induced hypertrophy and Ca2+ handling in differentiated satellite cells.


PMID 25229238

Abstract

Muscle regeneration involves the activation of satellite cells, is regulated at the genetic and epigenetic levels, and is strongly influenced by gene activation and environmental conditions. The aim of this study was to determine whether the overexpression of mIGF-1 can modify functional features of satellite cells during the differentiation process, particularly in relation to modifications of intracellular Ca2+ handling. Satellite cells were isolated from wild-type and MLC/mIGF-1 transgenic mice. The cells were differentiated in vitro, and morphological analyses, intracellular Ca2+ measurements, and ionic current recordings were performed. mIGF-1 overexpression accelerates satellite cell differentiation and promotes myotube hypertrophy. In addition, mIGF-1 overexpression-induced potentiation of myogenesis triggers both quantitative and qualitative changes to the control of intracellular Ca2+ handling. In particular, the differentiated MLC/mIGF-1 transgenic myotubes have reduced velocity and amplitude of intracellular Ca2+ increases after stimulation with caffeine, KCl and acetylcholine. This appears to be due, at least in part, to changes in the physico-chemical state of the sarcolemma (increased membrane lipid oxidation, increased output currents) and to increased expression of dihydropyridine voltage-operated Ca2+ channels. Interestingly, extracellular ATP and GTP evoke intracellular Ca2+ mobilization to greater extents in the MLC/mIGF-1 transgenic satellite cells, compared to the wild-type cells. These data suggest that these MLC/mIGF-1 transgenic satellite cells are more sensitive to trophic stimuli, which can potentiate the effects of mIGF-1 on the myogenic programme.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB4502027
Anti-ATP2A1 antibody produced in rabbit, affinity isolated antibody
SAB2104862
Anti-ATP2A1, (N-terminal) antibody produced in rabbit, affinity isolated antibody
SAB4300397
Anti-MYOD1 (Ab-200) antibody produced in rabbit, affinity isolated antibody
SAB2105139
Anti-MYOD1 antibody produced in rabbit, affinity isolated antibody
SAB1410813
Anti-MYOD1 antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
SAB2700849
Anti-QDPR antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
HPA058951
Anti-QDPR antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
WH0000487M1
Monoclonal Anti-ATP2A1 antibody produced in mouse, clone 1B11, purified immunoglobulin, buffered aqueous solution
SAB1403587
Monoclonal Anti-ATP2A1 antibody produced in mouse, clone 6F8, purified immunoglobulin, buffered aqueous solution
SAB1409379 Monoclonal Anti-ATP2A1 antibody produced in mouse, clone 2C9, ascites fluid, solution
SAB1409380 Monoclonal Anti-ATP2A1 antibody produced in mouse, clone 3H4, ascites fluid, solution
M6190 Monoclonal Anti-MYOD1 antibody produced in mouse, clone 5.2F, purified immunoglobulin, buffered aqueous solution
WH0004654M1
Monoclonal Anti-MYOD1 antibody produced in mouse, clone 1A7, purified immunoglobulin, buffered aqueous solution
SAB5300415
Monoclonal Anti-MYOD1 antibody produced in mouse, clone 1C8, ascites fluid
WH0005860M2
Monoclonal Anti-QDPR antibody produced in mouse, clone M1, purified immunoglobulin, buffered aqueous solution
SAB1404286
Monoclonal Anti-QDPR antibody produced in mouse, clone 2D4-1D3, purified immunoglobulin, buffered aqueous solution